Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of dyslipidemia and lipid-lowering therapy with statins in patients with neuroendocrine tumors.
Faggiano A, Russo F, Zamponi V, Sesti F, Puliani G, Modica R, Malandrino P, Ferraù F, Rinzivillo M, Di Muzio M, Di Simone E, Panattoni N, Dolce P, Lauretta R, Di Iasi G, Prinzi A, Alessi Y, Feola T, Mazzilli R, Appetecchia M, Giannetta E, Panzuto F, Colao A. Faggiano A, et al. Among authors: colao a. J Neuroendocrinol. 2024 Dec 26:e13485. doi: 10.1111/jne.13485. Online ahead of print. J Neuroendocrinol. 2024. PMID: 39726194
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study.
Brighi N, Panzuto F, Modica R, Gelsomino F, Albertelli M, Pusceddu S, Massironi S, Lamberti G, Rinzivillo M, Faggiano A, Spallanzani A, Ferone D, Prinzi N, Rossi RE, Annibale B, Colao AM, Campana D. Brighi N, et al. Among authors: colao am. Oncologist. 2020 Mar;25(3):259-265. doi: 10.1634/theoncologist.2019-0403. Epub 2019 Nov 6. Oncologist. 2020. PMID: 32162819 Free PMC article.
Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study.
Feola T, Puliani G, Sesti F, Modica R, Centello R, Minotta R, Cannavale G, Di Meglio S, Di Vito V, Lauretta R, Appetecchia M, Colao A, Lenzi A, Isidori AM, Faggiano A, Giannetta E. Feola T, et al. Among authors: colao a. J Endocrinol Invest. 2022 Apr;45(4):849-857. doi: 10.1007/s40618-021-01715-0. Epub 2022 Jan 18. J Endocrinol Invest. 2022. PMID: 35040099
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons.
Modica R, La Salvia A, Liccardi A, Cozzolino A, Di Sarno A, Russo F, Colao A, Faggiano A; NIKE group. Modica R, et al. Among authors: colao a. Endocrine. 2024 Aug;85(2):520-531. doi: 10.1007/s12020-024-03767-7. Epub 2024 Mar 20. Endocrine. 2024. PMID: 38509261 Free PMC article. Review.
Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience.
Massironi S, Campana D, Partelli S, Panzuto F, Rossi RE, Faggiano A, Brighi N, Falconi M, Rinzivillo M, Delle Fave G, Colao AM, Conte D. Massironi S, et al. Among authors: colao am. Ann Surg Oncol. 2018 Oct;25(11):3200-3206. doi: 10.1245/s10434-018-6673-5. Epub 2018 Jul 27. Ann Surg Oncol. 2018. PMID: 30054824
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study.
Ruggeri RM, Altieri B, Razzore P, Retta F, Sperti E, Scotto G, Brizzi MP, Zumstein L, Pia A, Lania A, Lavezzi E, Nappo G, Laffi A, Albertelli M, Boschetti M, Hasballa I, Veresani A, Prinzi N, Pusceddu S, Oldani S, Nichetti F, Modica R, Minotta R, Liccardi A, Cannavale G, Grossrubatscher EM, Tarsitano MG, Zamponi V, Zatelli MC, Zanata I, Mazzilli R, Appetecchia M, Davì MV, Guarnotta V, Giannetta E, La Salvia A, Fanciulli G, Malandrino P, Isidori AM, Colao A, Faggiano A; NIKE Group. Ruggeri RM, et al. Among authors: colao a. J Endocrinol Invest. 2024 Apr;47(4):959-971. doi: 10.1007/s40618-023-02213-1. Epub 2023 Oct 14. J Endocrinol Invest. 2024. PMID: 37837555 Free PMC article.
1,272 results